EPCAM and colorectal carcinoma: In the normal ME- CRCs, frequency of expression of the cell surface marker ESA reverts to that of non-CRC cells as the cells are serially passaged; in particular, ESA+, CD44+ CD49f+ subpopulation is significantly decreased with progressive passage.